Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting
2006 ◽
Vol 22
(5)
◽
pp. 967-969
◽
Craig J. Currie
◽
Phil McEwan
◽
Chris Poole
◽
William J. Valentine
◽
Andrew J. Palmer
◽
...
2005 ◽
Vol 21
(12)
◽
pp. 2063-2071
◽
William J. Valentine
◽
Andrew J. Palmer
◽
Morten Lammert
◽
Lars Nicklasson
◽
Volker Foos
◽
...
Craig J. Currie
◽
Phil McEwan
◽
Chris Poole
◽
William J. Valentine
◽
Andrew J. Palmer
◽
...
2004 ◽
Vol 7
(6)
◽
pp. 736-737
◽
M Lammert
◽
AJ Palmer
◽
S Roze
◽
ME Minshall
◽
WJ Valentine
◽
...
2013 ◽
Vol 16
(3)
◽
pp. A164
P.D. Home
◽
P. Soewondo
◽
A.A. Shafie
◽
K. AlRaddady
◽
R. Baadbad
◽
...
2005 ◽
Vol 8
(6)
◽
pp. A162
D Cobden
◽
L Nicklasson
◽
P Raskin
◽
A Garber
◽
JA Ray
◽
...
2009 ◽
Vol 12
(7)
◽
pp. A405-A406
E Suchankova
◽
T Doležal
◽
Z Pisarikova
◽
K Rychna
◽
D Bartaskova
2015 ◽
Vol 18
(4)
◽
pp. 263-272
◽
Vishal Gupta
◽
Ranya Baabbad
◽
Eva Hammerby
◽
Annie Nikolajsen
◽
Asrul Akmal Shafie
2018 ◽
Vol 20
(8)
◽
pp. 1921-1927
◽
Anthony H. Barnett
◽
Simon Arnoldini
◽
Barnaby Hunt
◽
Gowri Subramanian
◽
Christina Stentoft Hoxer
2018 ◽
Vol 20
(10)
◽
pp. 2371-2378
◽
Russell Drummond
◽
Samuel Malkin
◽
Michelle Du Preez
◽
Xin Ying Lee
◽
Barnaby Hunt
2010 ◽
Vol 13
(7)
◽
pp. A507
Close
Export Citation Format
Close
Share Document
Close